Target intelligence / Profile preview

Myosin heavy chain 10 (MYH10 (NM-IIB))

Target
MYH10 (NM-IIB)
Molecular classification
Motor protein, Cytoskeletal protein, Enzyme (ATPase activity), Myosin II family (Class II myosin)
01

Overview

Myosin heavy chain 10 is a conventional non-muscle myosin II motor protein encoded by the MYH10 gene. It functions as an actin-dependent ATPase, generating force for diverse cellular processes including cytokinesis, cell migration, maintenance of cell shape, and polarity[1][5]. NM-IIB is essential for normal cardiac muscle development and is the only non-muscle myosin II isoform expressed in cardiac muscle, where it localized to adherens junctions within intercalated discs[1]. Mutations in MYH10 are associated with developmental defects in the heart and brain, and single nucleotide polymorphisms in MYH10 have been linked to left atrial enlargement[1][5]. NM-IIB is composed of a globular motor domain (ATP and actin binding), a coiled-coil rod for dimerization, and associated light chains. It is ubiquitously expressed, with critical roles in cytoskeleton organization, cell division, and specialized functions such as secretion and cell capping[1][5]. MYH10 should not be confused with the unrelated unconventional myosin-10 (MYO10)[5].

Other names
Non-muscle myosin IIBNM-IIBMYH10Myosin-10NMMHCB
02

Mechanism of action

No established mechanism of action for therapeutic inhibition/activation; mechanisms target actin-myosin ATPase or cytoskeletal function in experimental contexts[5]

03

Biological functions

Cell motilityCytokinesisCell shape regulationCell polarityCytoskeleton organizationCell migrationCardiac muscle developmentCell adhesion
04

Disease associations

Congenital ptosisMicrophthalmia/coloboma 12Developmental brain defectsDevelopmental heart defectsLeft atrial enlargementMay-Hegglin anomaly (some confusion; primarily MYH9)
05

Safety considerations

Impaired cytokinesis and cell migration if inhibitedPotential effects on cardiac and brain developmentWidespread cellular perturbation due to cytoskeletal disruption[1][5]

Beyond the preview

Go deeper on Myosin heavy chain 10 (MYH10 (NM-IIB)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myosin heavy chain 10 (MYH10 (NM-IIB)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call